NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
55 hedge funds and large institutions have $168M invested in NKGen Biotech, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
55
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.17M | |
| 2 | +$4.62M | |
| 3 | +$3.24M | |
| 4 |
KL
KIM LLC
Wichita,
Kansas
|
+$3.04M |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$2.96M |
Top Sellers
| 1 | -$5.87M | |
| 2 | -$3.62M | |
| 3 | -$3.48M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.38M |
| 5 |
EC
Elequin Capital
New York
|
-$2.18M |